SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001144204-08-033836
Filing Date
2008-06-05
Accepted
2008-06-05 16:02:53
Documents
4

Document Format Files

Seq Description Document Type Size
1 v116625_s3-a.htm S-3/A 510147
2 v116625_ex23-1.htm EX-23.1 5724
3 v116625_ex23-2.htm EX-23.2 6030
4 filename4.htm CORRESP 569518
  Complete submission text file 0001144204-08-033836.txt   1092888
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: S-3/A | Act: 33 | File No.: 333-150562 | Film No.: 08883199
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1